SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-020570
Filing Date
2022-02-11
Accepted
2022-02-11 16:32:19
Documents
2
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm226079d4_sc13ga.htm SC 13G/A 73234
2 EXHIBIT 99.3 tm226079d4_ex99-3.htm EX-99.3 6217
  Complete submission text file 0001104659-22-020570.txt   81074
Mailing Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000
Business Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000 41-61-324-6210
Novartis Bioventures Ltd (Filed by) CIK: 0001297709 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 011441223261503
BICYCLE THERAPEUTICS plc (Subject) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-91023 | Film No.: 22621704
SIC: 2834 Pharmaceutical Preparations